Premia Global Advisors LLC purchased a new position in Metlife Inc (NYSE:MET) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,381 shares of the financial services provider’s stock, valued at approximately $170,000.
A number of other hedge funds have also recently modified their holdings of the stock. Stone Ridge Asset Management LLC bought a new stake in Metlife in the fourth quarter worth $1,225,000. Kendall Capital Management bought a new position in shares of Metlife during the fourth quarter valued at $366,000. Guggenheim Capital LLC lifted its holdings in shares of Metlife by 2.2% during the fourth quarter. Guggenheim Capital LLC now owns 1,255,125 shares of the financial services provider’s stock valued at $63,459,000 after purchasing an additional 26,421 shares in the last quarter. Virtue Capital Management LLC bought a new position in shares of Metlife during the fourth quarter valued at $735,000. Finally, Brandywine Global Investment Management LLC lifted its holdings in shares of Metlife by 2.9% during the fourth quarter. Brandywine Global Investment Management LLC now owns 975,583 shares of the financial services provider’s stock valued at $49,326,000 after purchasing an additional 27,611 shares in the last quarter. 77.67% of the stock is currently owned by institutional investors.
Metlife Inc (NYSE:MET) opened at $47.10 on Wednesday. Metlife Inc has a 1-year low of $43.38 and a 1-year high of $55.91. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.15 and a quick ratio of 0.15. The firm has a market capitalization of $48,742.96, a PE ratio of 13.81, a price-to-earnings-growth ratio of 0.95 and a beta of 1.28.
Metlife (NYSE:MET) last posted its earnings results on Tuesday, February 13th. The financial services provider reported $0.64 earnings per share for the quarter, missing analysts’ consensus estimates of $1.05 by ($0.41). Metlife had a net margin of 5.69% and a return on equity of 8.59%. The firm had revenue of $15.79 billion during the quarter, compared to the consensus estimate of $15.89 billion. During the same period in the prior year, the company posted $1.28 EPS. equities research analysts forecast that Metlife Inc will post 4.93 EPS for the current year.
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 13th. Shareholders of record on Monday, February 5th were issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 3.40%. The ex-dividend date of this dividend was Friday, February 2nd. Metlife’s dividend payout ratio is 46.92%.
A number of research analysts have recently issued reports on the company. Zacks Investment Research downgraded Metlife from a “buy” rating to a “hold” rating in a report on Monday, January 22nd. Wells Fargo & Co set a $62.00 price target on Metlife and gave the company a “buy” rating in a report on Thursday, December 14th. Deutsche Bank assumed coverage on Metlife in a report on Tuesday, January 2nd. They set a “hold” rating and a $55.00 price target on the stock. Goldman Sachs Group reaffirmed a “buy” rating on shares of Metlife in a report on Wednesday, January 31st. Finally, ValuEngine downgraded Metlife from a “strong-buy” rating to a “buy” rating in a report on Friday, February 2nd. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating, eight have given a buy rating and one has given a strong buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $57.90.
MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.